End-seq – map both 5’ and 3’ transcript ends genome-wide at single nucleotide resolution in 3 days

At Eclipse BioInnovations (Eclipse Bio), we create tools that simplify, accelerate and advance RNA research. End-Seq technology is a recent development at Eclipse Bio, which we are excited to officially launch this month. Eclipse’s End-Seq products enable researchers to map both 5’ and 3’ transcript ends genome-wide at single nucleotide resolution in just 3 short days, and overcome several drawbacks associated with previous methods used to map transcript ends like long protocols and low-resolution data.